Lista de obras -

A genetic risk score to guide age-specific, personalized prostate cancer screening

A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk

scientific article published on 29 July 2013

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

artículo científico publicado en 2014

A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease

artículo científico publicado en 2012

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

artículo científico publicado en 2018

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

scholarly article published in Nature Genetics

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

scholarly article published in Nature Genetics

CHEK2 (∗) 1100delC Mutation and Risk of Prostate Cancer

artículo científico publicado en 2014

CHEK2*1100delC and risk of malignant melanoma: Danish and German studies and meta-analysis

artículo científico publicado en 2011

CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls

artículo científico publicado en 2008

CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer

artículo científico publicado en 2012

Calcineurin inhibitors and rapamycin: cancer protection or promotion?

artículo científico publicado en 2007

Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression

artículo científico publicado en 2013

Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression.

artículo científico publicado en 2013

Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer

artículo científico publicado en 2014

Genotyping for NOD2 genetic variants and crohn disease: a metaanalysis

artículo científico publicado en 2009

High tobacco consumption is causally associated with increased all-cause mortality in a general population sample of 55 568 individuals, but not with short telomeres: a Mendelian randomization study

artículo científico publicado en 2014

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

artículo científico publicado en 2013

Increased Body Mass Index, Elevated C-reactive Protein, and Short Telomere Length

artículo científico publicado en 2014

Increased risk of breast cancer associated with CHEK2*1100delC

artículo científico publicado en 2006

Missense polymorphisms in BRCA1 and BRCA2 and risk of breast and ovarian cancer.

artículo científico publicado en 2009

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

artículo científico publicado en 2013

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

artículo científico publicado en 2015

No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study

scientific article published on 01 January 2004

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

artículo científico publicado en 2016

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts

artículo científico publicado en 2018

Prothrombin and risk of venous thromboembolism, ischemic heart disease and ischemic cerebrovascular disease in the general population

Response

artículo científico publicado en 2013

Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci

artículo científico publicado en 2015

Risk of cancer by ATM missense mutations in the general population.

artículo científico publicado en 2008

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study

artículo científico publicado en 2011

Short telomere length, cancer survival, and cancer risk in 47102 individuals

artículo científico publicado en 2013

Short telomere length, lung function and chronic obstructive pulmonary disease in 46,396 individuals.

artículo científico publicado en 2012

Short telomere length, myocardial infarction, ischemic heart disease, and early death

artículo científico publicado en 2011

Telomere shortening unrelated to smoking, body weight, physical activity, and alcohol intake: 4,576 general population individuals with repeat measurements 10 years apart

artículo científico publicado en 2014

Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

artículo científico publicado en 2021

Lista de obras de

A genetic risk score to guide age-specific, personalized prostate cancer screening

A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

CHEK2 (∗) 1100delC Mutation and Risk of Prostate Cancer

CHEK2*1100delC and risk of malignant melanoma: Danish and German studies and meta-analysis

CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls

CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer

Calcineurin inhibitors and rapamycin: cancer protection or promotion?

Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression

Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression.

Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer

Genotyping for NOD2 genetic variants and crohn disease: a metaanalysis

High tobacco consumption is causally associated with increased all-cause mortality in a general population sample of 55 568 individuals, but not with short telomeres: a Mendelian randomization study

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

Increased Body Mass Index, Elevated C-reactive Protein, and Short Telomere Length

Increased risk of breast cancer associated with CHEK2*1100delC

Missense polymorphisms in BRCA1 and BRCA2 and risk of breast and ovarian cancer.

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts

Prothrombin and risk of venous thromboembolism, ischemic heart disease and ischemic cerebrovascular disease in the general population

Response

Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci

Risk of cancer by ATM missense mutations in the general population.

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study

Short telomere length, cancer survival, and cancer risk in 47102 individuals

Short telomere length, lung function and chronic obstructive pulmonary disease in 46,396 individuals.

Short telomere length, myocardial infarction, ischemic heart disease, and early death

Telomere shortening unrelated to smoking, body weight, physical activity, and alcohol intake: 4,576 general population individuals with repeat measurements 10 years apart

Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction